Logo of Huzzle

Clinical Research Fellow - Experimental Cancer Medicine

  • Job
    Full-time
    Mid Level
  • Research & Development
    Healthcare
  • Manchester

AI generated summary

  • You should have an interest in early phase clinical trials, complete IMT by August 2026, and be ready to manage trial patients in outpatient and inpatient settings.
  • You will manage trial patients, participate in meetings, handle administrative duties, assist in study planning, and engage in research writing and presentations while ensuring high-quality patient care.

Requirements

  • We seek an ambitious, innovative individual with a specific interest in early phase clinical trials to act as sub-investigator for a growing portfolio of complex clinical trials.
  • The position is suitable for individuals who have or expect to complete IMT by August 2026, through to those having completed their specialist training in Oncology, and who wish to gain further experience in experimental medicine and Phase I trials, including first-in-human trials, clinical pharmacology trials and translational research.
  • Candidates are encouraged to discuss this asap.
  • Start date: Summer 2026
  • You will be expected to participate in these studies as a sub-investigator.
  • You will be involved in managing all aspects of trial patients (both in outpatient & in-patients setting), across a diverse range of solid tumours, through new patient consultation, consent & screening patients & reviewing patients at follow-up appointments.
  • You will be expected to attend safety review committee meetings to discuss trial patients.
  • You will be expected to attend monthly molecular tumour board meetings to discuss trial patients and to agree opportunities for patients to enrol in early phase trials.
  • You will be expected to undertake the administrative duties associated with the care of our patients.
  • You will be given opportunities and will be encouraged to be involved in the development & planning of new studies.
  • You will be expected to be involved in writing papers & reviews.
  • You will also be required to undergo an annual appraisal.
  • The postholder will contribute to the delivery of high‑quality consultant‑led care across 7 days.
  • This includes participation in planned weekend and weekday clinical activity to support safe, timely decision‑making and continuity of care for patients.

Responsibilities

  • You will be responsible for seeing new referrals, follow-ups & managing the patient throughout all aspects of their trial experience.
  • You will take an active role in these meetings gaining valuable experience in using these data to identify and define suitable trial options for patients.
  • Following training, you will be expected to participate in these studies as a sub-investigator.
  • You will be involved in managing all aspects of trial patients (both in outpatient & in-patients setting), across a diverse range of solid tumours, through new patient consultation, consent & screening patients & reviewing patients at follow-up appointments.
  • You will be expected to attend safety review committee meetings to discuss trial patients.
  • You will interface with external stakeholders such as CROs & pharmaceutical sponsors.
  • You will be expected to attend monthly molecular tumour board meetings to discuss trial patients and to agree opportunities for patients to enrol in early phase trials.
  • You will be expected to undertake the administrative duties associated with the care of our patients.
  • You will be given opportunities and will be encouraged to be involved in the development & planning of new studies.
  • There is potential to present your research work & you will be expected to be involved in writing papers & reviews.
  • You will also be required to undergo an annual appraisal.
  • The postholder will contribute to the delivery of high‑quality consultant‑led care across 7 days.
  • This includes participation in planned weekend and weekday clinical activity to support safe, timely decision‑making and continuity of care for patients.

FAQs

What is the role of the Clinical Research Fellow - Experimental Cancer Medicine?

The role involves acting as a sub-investigator for early phase clinical trials, managing patient care throughout their trial experience, and participating in molecular tumour board meetings to identify suitable trial options.

What qualifications are required for this position?

Candidates should have completed or expect to complete IMT by August 2026, or have completed their specialist training in Oncology, with an interest in experimental medicine and Phase I trials.

What types of clinical trials will I be involved in?

You will be involved in a diverse range of clinical trials, including phase I trials of small molecule inhibitors, next-generation chemotherapy trials, combination/multi-modality phase I trials, molecular characterization/translational studies, and radiotherapy trials.

What are the working hours for this position?

This is a 10 session non-training post, with participation in planned weekend and weekday clinical activity to ensure continuity of care for patients.

How will I be supported in my role?

You will work alongside a team of consultants, research nurses, clinical trial coordinators, and other professionals, with opportunities to contribute to the development of new studies and engage in research work.

Where is the position based?

The position is located at The Christie, one of Europe’s leading cancer centres, based in Manchester.

What are my responsibilities regarding patient management?

You will manage all aspects of trial patients, including new patient consultations, consent, screening, and follow-up appointments in both outpatient and inpatient settings.

Is there an opportunity for research involvement?

Yes, you will have the potential to present your research work and will be expected to be involved in writing papers and reviews.

Who can I contact for more information about the position?

For further details or informal visits, you can contact Amanda Rees, Head of Research Operations, at amanda.rees14@nhs.net, or Dr. Donna Graham, Consultant Medical Oncologist, at donna.graham8@nhs.net.

The Christie NHS Foundation Trust is one of Europe’s leading cancer centres, treating more than 44,000 patients a year.

Science & Healthcare
Industry
1001-5000
Employees
1932
Founded Year

Mission & Purpose

The Christie NHS Foundation Trust, based in Manchester, specializes in cancer care and provides a range of services including treatment, research, and support for cancer patients. Their mission is to deliver world-class, patient-centered care and to lead in cancer research and innovation. The Trust aims to improve cancer outcomes and quality of life through cutting-edge treatments, comprehensive care, and a commitment to advancing cancer research.